<DOC>
	<DOCNO>NCT02857907</DOCNO>
	<brief_summary>The aim study investigate impact Anti-Thymocyte Globulin ( ATG ) immune senescence . Markers immune senescence expression assess prospective cohort renal transplant recipient day transplantation one year renal transplantation .</brief_summary>
	<brief_title>Anti-thymocyte Globulin-induced Immune Senescence</brief_title>
	<detailed_description>The anti-thymocyte globulin ( ATG ) use prevention treatment acute rejection organ transplantation . They origin brutal CD4 lymphocyte depletion follow gradual recovery lymphocyte pool . Nevertheless , CD4 lymphopenia persist patient . SIGAL study aim characterize immune response lymphopenic patient ( administration ATG ) order identify possible similarity immunosenescence.The immunosenescence complex profound remodel immune system life . It mainly due thymic involution repeat antigenic stimulation .</detailed_description>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<criteria>Patient able understand reason study Signature inform consent Patient wait renal transplant Inability understand reason study ; psychiatric disorder Any history last 2 year immunosuppressive therapy ( except steroid ) History cancer ( except skin cancer ) treat hematological malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Kidney transplantation</keyword>
	<keyword>Immunosuppressive treatment</keyword>
</DOC>